Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma

Mark Yarchoan^#¹, Parul Agarwal^#², Augusto Villanueva³, Shuyun Rao⁴, Laura A Dawson⁵, Josep M Llovet^{6

7

8}, Richard S Finn⁹, John D Groopman¹⁰, Hashem B El-Serag¹¹, Satdarshan P Monga¹², Xin Wei Wang¹³, Michael Karin¹⁴, Robert E Schwartz¹⁵, Kenneth K Tanabe¹⁶, Lewis R Roberts¹⁷, Preethi H Gunaratne¹⁸, Allan Tsung¹⁹, Kimberly A Brown²⁰, Theodore S Lawrence²¹, Riad Salem²², Amit G Singal²³, Amy K Kim²⁴, Atoosa Rabiee²⁵, Linda Resar²⁴, Yujin Hoshida²³, Aiwu Ruth He²⁶, Kalpana Ghoshal²⁷, Patrick B Ryan²⁸, Elizabeth M Jaffee¹, Chandan Guha²⁹, Lopa Mishra^{4

25}, C Norman Coleman³⁰, Mansoor M Ahmed³¹

Affiliations

¹ Department of Oncology Gastrointestinal Cancer, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
² Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
³ Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ Department of Surgery, Center for Translational Medicine, George Washington University, Washington D.C.
⁵ Department of Radiation Oncology, University of Toronto, Toronto, Ontario.
⁶ Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
⁷ Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, CIBERehd, Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
⁸ Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
⁹ Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Santa Monica, California.
¹⁰ Department of Environmental Health and Engineering, Epidemiology, Johns Hopkins, Bloomberg School of Public Health, Baltimore, Maryland.
¹¹ Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas.
¹² Department of Pathology and Medicine, and Pittsburgh Liver Research Center, University of Pittsburgh, and University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
¹³ Department of Human Carcinogenesis, NCI, Bethesda, Maryland.
¹⁴ Department of Pharmacology, University of California, San Diego School of Medicine, San Diego, California.
¹⁵ Department of Gastroenterology and Hepatology, Sanford I. Weill Medical College of Cornell University, New York, New York.
¹⁶ Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts.
¹⁷ Department of Medicine, Mayo Clinic, Rochester, Minnesota.
¹⁸ Department of Biology and Biochemistry, University of Houston, Houston, Texas.
¹⁹ Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
²⁰ Department of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan.
²¹ Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
²² Department of Radiology, Feinberg School of Medicine, Chicago, Illinois.
²³ Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
²⁴ Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
²⁵ Department of Gastroenterology and Hepatology, VA Medical Center, Washington, D.C.
²⁶ Department of Medicine and Oncology, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, D.C.
²⁷ Department of Pathology, The Ohio State University College of Medicine, Columbus, Ohio.
²⁸ Janssen Research & Development, LLC, Titusville, New Jersey.
²⁹ Department of Radiation Oncology, Pathology and Urology, Albert Einstein College of Medicine, Bronx, New York.
³⁰ Division of Cancer Treatment and Diagnosis, Radiation Research Program, NCI, Rockville, Maryland. ahmedmm@mail.nih.gov norman.coleman@nih.gov.
³¹ Division of Cancer Treatment and Diagnosis, Molecular Radiation Therapeutics, Radiation Research Program, NCI, Rockville, Maryland. ahmedmm@mail.nih.gov norman.coleman@nih.gov.

^# Contributed equally.

PMID: 31481419
PMCID: PMC8330805
DOI: 10.1158/0008-5472.CAN-19-0803

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma

Mark Yarchoan et al. Cancer Res. 2019.

. 2019 Sep 1;79(17):4326-4330.

doi: 10.1158/0008-5472.CAN-19-0803.

Authors

Affiliations

¹ Department of Oncology Gastrointestinal Cancer, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
² Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
³ Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ Department of Surgery, Center for Translational Medicine, George Washington University, Washington D.C.
⁵ Department of Radiation Oncology, University of Toronto, Toronto, Ontario.
⁶ Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
⁷ Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, CIBERehd, Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
⁸ Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
⁹ Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Santa Monica, California.
¹⁰ Department of Environmental Health and Engineering, Epidemiology, Johns Hopkins, Bloomberg School of Public Health, Baltimore, Maryland.
¹¹ Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas.
¹² Department of Pathology and Medicine, and Pittsburgh Liver Research Center, University of Pittsburgh, and University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
¹³ Department of Human Carcinogenesis, NCI, Bethesda, Maryland.
¹⁴ Department of Pharmacology, University of California, San Diego School of Medicine, San Diego, California.
¹⁵ Department of Gastroenterology and Hepatology, Sanford I. Weill Medical College of Cornell University, New York, New York.
¹⁶ Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts.
¹⁷ Department of Medicine, Mayo Clinic, Rochester, Minnesota.
¹⁸ Department of Biology and Biochemistry, University of Houston, Houston, Texas.
¹⁹ Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
²⁰ Department of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan.
²¹ Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
²² Department of Radiology, Feinberg School of Medicine, Chicago, Illinois.
²³ Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
²⁴ Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
²⁵ Department of Gastroenterology and Hepatology, VA Medical Center, Washington, D.C.
²⁶ Department of Medicine and Oncology, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, D.C.
²⁷ Department of Pathology, The Ohio State University College of Medicine, Columbus, Ohio.
²⁸ Janssen Research & Development, LLC, Titusville, New Jersey.
²⁹ Department of Radiation Oncology, Pathology and Urology, Albert Einstein College of Medicine, Bronx, New York.
³⁰ Division of Cancer Treatment and Diagnosis, Radiation Research Program, NCI, Rockville, Maryland. ahmedmm@mail.nih.gov norman.coleman@nih.gov.
³¹ Division of Cancer Treatment and Diagnosis, Molecular Radiation Therapeutics, Radiation Research Program, NCI, Rockville, Maryland. ahmedmm@mail.nih.gov norman.coleman@nih.gov.

^# Contributed equally.

PMID: 31481419
PMCID: PMC8330805
DOI: 10.1158/0008-5472.CAN-19-0803

Erratum in

Correction: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.
Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson L, Karasic T, Llovet J, Finn R, Groopman J, El-Serag H, Monga S, Wang XW, Karin M, Schwartz R, Tanabe K, Roberts L, Gunaratne P, Tsung A, Brown K, Lawrence T, Salem R, Singal A, Kim A, Rabiee A, Resar L, Meyer J, Hoshida Y, He AR, Ghoshal K, Ryan P, Jaffee E, Guha C, Mishra L, Coleman N, Ahmed M. Yarchoan M, et al. Cancer Res. 2019 Nov 15;79(22):5897. doi: 10.1158/0008-5472.CAN-19-2958. Cancer Res. 2019. PMID: 31772073 No abstract available.

Abstract

Hepatocellular carcinoma (HCC) has emerged as a major cause of cancer deaths globally. The landscape of systemic therapy has recently changed, with six additional systemic agents either approved or awaiting approval for advanced stage HCC. While these agents have the potential to improve outcomes, a survival increase of 2-5 months remains poor and falls short of what has been achieved in many other solid tumor types. The roles of genomics, underlying cirrhosis, and optimal use of treatment strategies that include radiation, liver transplantation, and surgery remain unanswered. Here, we discuss new treatment opportunities, controversies, and future directions in managing HCC.

PubMed Disclaimer

References

1. El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology 2014;60: 1767–75. - PMC - PubMed
1. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018;391: 1301–14. - PubMed
1. Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol 2018;68:526–49. - PMC - PubMed
1. Cancer Genome Atlas Research Network. Electronic address, w.b.e. and N. Cancer Genome Atlas Research, comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 2017;169: 1327–41. - PMC - PubMed
1. Chen J, Zaidi S, Rao S, Chen JS, Phan L, Farci P, et al. Analysis of genomes and transcriptomes of hepatocellular carcinomas identifies mutations and gene expression changes in the transforming growth factor-beta pathway. Gastroenterology 2018;154:195–210. - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma

Affiliations

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma

Authors

Affiliations

Erratum in

Abstract

References

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous